Sat.Nov 11, 2023

article thumbnail

Wegovy cuts risk of heart attacks in milestone cardiovascular trial

STAT

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss. The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%.

Insurance 145
article thumbnail

Expert: Black Students Face Unique Challenges When Entering, Considering Pharmacy Residency Programs

Pharmacy Times

Experts discuss challenges and recommendations for addressing diversity, equity, and inclusion in pharmacy programs for minority students.

136
136
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: After decades in use, heart stents finally beat placebo. It took a bold researcher

STAT

PHILADELPHIA — A new study, and the bold doctor who led it, could result in big questions about how researchers study medical devices and surgical treatments and, eventually, what procedures patients undergo. It starts with coronary angioplasty, one of the most common procedures in medicine, performed hundreds of thousands of times a year in the U.S. alone.

143
143
article thumbnail

EzriCare Eye Drops Recall: Unveiling a Nationwide Health Crisis

Roots Analysis

The Centers for Disease Control and Prevention (CDC) recently issued a formal health advisory in response to an unprecedented outbreak of carbapenem-resistant Pseudomonas aeruginosa (CRPA), a bacterium notorious for its resistance to specific antibiotics, thereby instigating severe infections in affected individuals. This concerning development has been traced back to the utilization of EzriCare Artificial Tears Eye Drops.

FDA 52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Vacancy rate in Boston-area lab space climbs to 10-year high

STAT

As Massachusetts biotech companies slash jobs and face dwindling investments , it appears that the long-red-hot   real estate market for life sciences space in the area is continuing to follow a similar downward trend. Lab space vacancies in the Boston area hit a 10-year high in the third quarter, reaching an 11.7% availability rate, according to a report by real estate firm Colliers.

124
124
article thumbnail

Importance of medicines optimisation evident from latest NHS England prescribing costs

Hospital Pharmacy Europe

Figures revealing NHS England’s prescribing costs highlight the ‘vital role of pharmacists in medicines optimisation’, the chair of the Royal Pharmaceutical Society (RPS) in England has said. Figures released by the NHS Business Services Authority (NHSBSA) reveal that in the financial year 2022/23, the cost of medicines issued in hospitals was £9.45bn, making up 49.2% of its total medicines expenditure.

More Trending

article thumbnail

Impact of pharmacist independent prescribing on UK hospital practice highlighted by CPhO

Hospital Pharmacy Europe

Pharmacists were encouraged to think about what the profession is wanting to achieve with the advent of profession-wide independent prescribing during a recent panel discussion between three of the UK’s chief pharmaceutical officers (CPhOs). Speaking at the Royal Pharmaceutical Society’s Annual Conference 2023, David Webb, CPhO for England said that the profession also needs to be thinking about what kind of change independent prescribing will bring to hospital practice from 2026.

article thumbnail

Imodium interactions to avoid

The Checkup by Singlecare

Key takeaways | Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor A common component of household medicine cabinets, Imodium ( loperamide ), is an over-the-counter ( OTC ) antidiarrheal prescribed to treat diarrhea , dysentery , traveler’s diarrhea , chronic diarrhea , or high ileostomy output.

article thumbnail

Pharmaceutical Executive: November 2023 Issue (PDF)

PharmExec

Click the title above for a link to open the Pharmaceutical Executive November 2023 issue in an interactive PDF format.

52
article thumbnail

Autism and Maternal Immune Activation: Groundbreaking Insights

Roots Analysis

Infantile amnesia, the mysterious phenomenon where memories from early childhood seem to slip away, has long intrigued scientists and psychologists alike. Recent groundbreaking research from Trinity College Dublin has unveiled a compelling link between maternal immune activation during pregnancy, autism, and the persistence of early memories into adulthood.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.